[HTML][HTML] Resilience to resistance of HIV-1 protease inhibitors: profile of darunavir
E Lefebvre, CA Schiffer - AIDS reviews, 2008 - ncbi.nlm.nih.gov
The current effectiveness of HAART in the management of HIV infection is compromised by
the emergence of extensively cross-resistant strains of HIV-1, requiring a significant need for …
the emergence of extensively cross-resistant strains of HIV-1, requiring a significant need for …
Confronting the emergence of drug-resistant HIV type 1: impact of antiretroviral therapy on individual and population resistance
ES Daar, DD Richman - AIDS Research & Human Retroviruses, 2005 - liebertpub.com
Resistance to antiretroviral agents, and in particular the increasing levels of transmitted
resistant virus could offset the substantial gains won with potent antiretroviral therapy …
resistant virus could offset the substantial gains won with potent antiretroviral therapy …
Prevalence of antiretroviral drug resistance mutations in chronically HIV–infected, treatment-naive patients: implications for routine resistance screening before …
RM Novak, L Chen, RD MacArthur… - Clinical infectious …, 2005 - academic.oup.com
Background. The prevalence of drug resistance among persons with newly acquired human
immunodeficiency virus (HIV) infection is well documented. However, it is unclear to what …
immunodeficiency virus (HIV) infection is well documented. However, it is unclear to what …
Updated European recommendations for the clinical use of HIV drug resistance testing
AM Vandamme, A Sönnerborg, M Ait-Khaled… - Antiviral …, 2004 - journals.sagepub.com
In most European countries, HIV drug resistance testing has become a routine clinical tool.
However, its practical implementation in a clinical context is demanding. The European HIV …
However, its practical implementation in a clinical context is demanding. The European HIV …
Primary HIV drug resistance and efficacy of first-line antiretroviral therapy guided by resistance testing
M Oette, R Kaiser, M Däumer, R Petch… - JAIDS Journal of …, 2006 - journals.lww.com
Background: Primary HIV drug resistance has been associated with poor treatment outcome
of first-line highly active antiretroviral therapy (HAART) in several trials. The aim of the study …
of first-line highly active antiretroviral therapy (HAART) in several trials. The aim of the study …
Genetic diversity and drug resistance of human immunodeficiency virus type 1 (HIV-1) strains circulating in Shanghai
P Zhong, Q Pan, Z Ning, Y Xue, J Gong… - AIDS research and …, 2007 - liebertpub.com
The HIV-1 epidemic in Shanghai is rapidly increasing. To better understand the HIV-1
genetic diversity and the mutations associated with resistance to protease inhibitors (PIs) …
genetic diversity and the mutations associated with resistance to protease inhibitors (PIs) …
The global status of resistance to antiretroviral drugs
S Vella, L Palmisano - Clinical infectious diseases, 2005 - academic.oup.com
Since 1989, the emergence of resistant human immunodeficiency virus mutants has been
documented for any new antiretroviral agent introduced in the clinical setting; it is a major …
documented for any new antiretroviral agent introduced in the clinical setting; it is a major …
Is the male genital tract really a sanctuary site for HIV? Arguments that it is not
SH Lowe, SUC Sankatsing, S Repping, F vander Veen… - Aids, 2004 - journals.lww.com
One concern with current antiretroviral therapy for infection with HIV is that certain
anatomical sites in the body are considered 'sanctuary sites'. What is commonly meant is …
anatomical sites in the body are considered 'sanctuary sites'. What is commonly meant is …
High-risk sexual behavior in adults with genotypically proven antiretroviral-resistant HIV infection
PV Chin-Hong, SG Deeks, T Liegler… - JAIDS Journal of …, 2005 - journals.lww.com
Background: The substantial frequency of drug resistance in persons recently infected with
HIV implies exposure among HIV-uninfected individuals to HIV-infected persons with drug …
HIV implies exposure among HIV-uninfected individuals to HIV-infected persons with drug …
Prevalence of resistance-associated mutations in newly diagnosed HIV-1 patients in Greece
D Paraskevis, E Magiorkinis, A Katsoulidou… - Virus research, 2005 - Elsevier
The prevalence of HIV-1 drug resistance mutations in naïve patients has been previously
shown to differ greatly with the geographic origin. The purpose of this study was to …
shown to differ greatly with the geographic origin. The purpose of this study was to …